Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

SRx Health Solutions (SRXH) Receivables - Other (2024 - 2025)

SRx Health Solutions' Receivables - Other history spans 2 years, with the latest figure at $2.9 million for Q3 2025.

For Q3 2025, Receivables - Other rose 3033.7% year-over-year to $2.9 million; the TTM value through Sep 2025 reached $2.9 million, up 3033.7%, while the annual FY2025 figure was $2.9 million, N/A changed from the prior year.
Receivables - Other reached $2.9 million in Q3 2025 per SRXH's latest filing, up from $2.5 million in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $2.9 million in Q3 2025 to a low of $92000.0 in Q3 2024.